TOI (STOCKS)
The Oncology Institute, Inc. Common Stock
$2.510000
+0.125000 (+5.24%)
Prev close: $2.385000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Daniel Virnich
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $246.94M
- Employees
- 825
- P/E (TTM)
- -3.90
- P/B (TTM)
- -19.95
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.14 | $-0.11 | -0.0255 | -22.27% |
|
Jun 2025 (Q2)
|
$-0.15 | $-0.13 | -0.0187 | -14.24% |
|
Mar 2025 (Q1)
|
$-0.17 | $0.00 | +0.0000 | +0.00% |
|
Sep 2024 (Q3)
|
$-0.18 | $-0.06 | -0.1194 | -197.03% |
Financial Statements
| Revenues | $461.04M |
| Benefits Costs and Expenses | $527.45M |
| Costs And Expenses | $527.45M |
| Nonoperating Income/Loss | -$25.31M |
| Operating Expenses | $502.14M |
| Selling, General, and Administrative Expenses | $102.39M |
| Depreciation and Amortization | $7.02M |
| Other Operating Expenses | $392.73M |
| Operating Income/Loss | -$41.11M |
| Income/Loss From Continuing Operations After Tax | -$66.28M |
| Income/Loss From Continuing Operations Before Tax | -$66.28M |
| Income Tax Expense/Benefit | -$131.00K |
| Income Tax Expense/Benefit, Deferred | -$32.00K |
| Net Income/Loss | -$66.28M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$66.28M |
| Net Income/Loss Available To Common Stockholders, Basic | -$57.68M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$8.60M |
| Preferred Stock Dividends And Other Adjustments | -$5.09M |
| Basic Earnings Per Share | -$0.64 |
| Diluted Earnings Per Share | -$0.64 |
| Basic Average Shares | 89,539,071 |
| Diluted Average Shares | 89,539,071 |
| Assets | $163.62M |
| Current Assets | $110.09M |
| Inventory | $18.88M |
| Other Current Assets | $91.21M |
| Noncurrent Assets | $53.53M |
| Fixed Assets | $10.71M |
| Intangible Assets | $11.73M |
| Other Non-current Assets | $31.08M |
| Liabilities | $175.89M |
| Current Liabilities | $65.58M |
| Accounts Payable | $35.63M |
| Wages | $8.00M |
| Other Current Liabilities | $21.94M |
| Noncurrent Liabilities | $110.31M |
| Commitments and Contingencies | $0.00 |
| Equity | -$12.27M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$12.27M |
| Liabilities And Equity | $163.62M |
| Net Cash Flow From Operating Activities | -$23.82M |
| Net Cash Flow From Operating Activities, Continuing | -$23.82M |
| Net Cash Flow From Investing Activities | -$3.77M |
| Net Cash Flow From Investing Activities, Continuing | -$3.77M |
| Net Cash Flow From Financing Activities | $7.66M |
| Net Cash Flow From Financing Activities, Continuing | $7.66M |
| Net Cash Flow | -$18.01M |
| Net Cash Flow, Continuing | -$18.01M |
| Comprehensive Income/Loss | -$66.28M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$66.28M |
| Other Comprehensive Income/Loss | $0.00 |